Effects of incretin-based therapy on other obesity-related comorbidities Incretin-based AOM might be beneficial for most of obesity-related comorbidities, notwithstanding their metabolic, load-bearing, and mixed pathogenesis (Fig
Adoption of the Emergency Care Access & Timeliness eCQM Beginning With Voluntary Reporting for the CY 2027 Reporting Period Followed by Mandatory Reporting Beginning With the CY 2028 Reporting Period/CY 2030 Payment Determination a
Kawasaki T, Okamoto K, Kawasaki C, Sata T
2,6 Two critical enzymes involved in the conversion of L-carnitine to TMA are carnitine oxygenase (CntA) and carnitine reductase (CntB)
Bifidobacteria [83] were potent in reducing ES-induced peripheral [83], neuro- [81] and gut inflammation [87] potentially contributing to the modulatory effects on some of the behavioral domains